These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 1982446)

  • 21. Monoamine oxidase in pancreatic islets, exocrine pancreas, and liver from rats. Characterization with clorgyline, deprenyl, pargyline, tranylcypromine, and amezinium.
    Lenzen S; Nahrstedt H; Panten U
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Nov; 324(3):190-5. PubMed ID: 6419132
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Brain monoamine oxidase A inhibition in cigarette smokers.
    Fowler JS; Volkow ND; Wang GJ; Pappas N; Logan J; Shea C; Alexoff D; MacGregor RR; Schlyer DJ; Zezulkova I; Wolf AP
    Proc Natl Acad Sci U S A; 1996 Nov; 93(24):14065-9. PubMed ID: 8943061
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insufficient recovery of monoamine oxidase in a bioequivalence study of the monoamine oxidase inhibitor tranylcypromine: Recommendation of the tranylcypromine enantiomer test.
    Ulrich S; Hock D; Guth V; Erenmemisoglu A; Scheidel B
    Int J Clin Pharmacol Ther; 2022 May; 60(5):242-252. PubMed ID: 35279222
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of phenelzine and other monoamine oxidase inhibitor antidepressants on brain and liver I2 imidazoline-preferring receptors.
    Alemany R; Olmos G; García-Sevilla JA
    Br J Pharmacol; 1995 Feb; 114(4):837-45. PubMed ID: 7773544
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liquid chromatographic and tandem mass spectrometric assay for evaluation of in vivo inhibition of rat brain monoamine oxidases (MAO) A and B following a single dose of MAO inhibitors: application of biomarkers in drug discovery.
    Lang W; Masucci JA; Caldwell GW; Hageman W; Hall J; Jones WJ; Rafferty BM
    Anal Biochem; 2004 Oct; 333(1):79-87. PubMed ID: 15351283
    [TBL] [Abstract][Full Text] [Related]  

  • 26. On the formation and nature of the imidazoline I2 binding site on human monoamine oxidase-B.
    McDonald GR; Olivieri A; Ramsay RR; Holt A
    Pharmacol Res; 2010 Dec; 62(6):475-88. PubMed ID: 20832472
    [TBL] [Abstract][Full Text] [Related]  

  • 27. N-(2-cyanoethyl)tranylcypromine, a potential prodrug of tranylcypromine: its disposition and interaction with catecholamine neurotransmitters in brain.
    Nazarali AJ; Baker GB; Coutts RT; Wong TF
    Pharm Res; 1987 Feb; 4(1):16-20. PubMed ID: 3508523
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of monoamine oxidase by 8-[(phenylethyl)sulfanyl]caffeine analogues.
    Mostert S; Mentz W; Petzer A; Bergh JJ; Petzer JP
    Bioorg Med Chem; 2012 Dec; 20(24):7040-50. PubMed ID: 23122934
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of moclobemide on rat brain monoamine oxidase A and B: comparison with harmaline and clorgyline.
    Gerardy J
    Prog Neuropsychopharmacol Biol Psychiatry; 1994 Jul; 18(4):793-802. PubMed ID: 7938567
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic MAO A and MAO B inhibition decreases the 5-HT1A receptor-mediated inhibition of forskolin-stimulated adenylate cyclase.
    Sleight AJ; Marsden CA; Palfreyman MG; Mir AK; Lovenberg W
    Eur J Pharmacol; 1988 Sep; 154(3):255-61. PubMed ID: 3234480
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of gestational exposure to monoamine oxidase inhibitors in rats: preliminary behavioral and neurochemical studies.
    Whitaker-Azmitia PM; Zhang X; Clarke C
    Neuropsychopharmacology; 1994 Oct; 11(2):125-32. PubMed ID: 7840864
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of monoamine oxidase in monoaminergic neurones in the rat brain by irreversible inhibitors.
    Fagervall I; Ross SB
    Biochem Pharmacol; 1986 Apr; 35(8):1381-7. PubMed ID: 2870717
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tranylcypromine enhancement of nicotine self-administration.
    Villégier AS; Lotfipour S; McQuown SC; Belluzzi JD; Leslie FM
    Neuropharmacology; 2007 May; 52(6):1415-25. PubMed ID: 17412372
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lipophilicity plays a major role in modulating the inhibition of monoamine oxidase B by 7-substituted coumarins.
    Carotti A; Altomare C; Catto M; Gnerre C; Summo L; De Marco A; Rose S; Jenner P; Testa B
    Chem Biodivers; 2006 Feb; 3(2):134-49. PubMed ID: 17193252
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pure enantiomers of benzoylamino-tranylcypromine: LSD1 inhibition, gene modulation in human leukemia cells and effects on clonogenic potential of murine promyelocytic blasts.
    Valente S; Rodriguez V; Mercurio C; Vianello P; Saponara B; Cirilli R; Ciossani G; Labella D; Marrocco B; Monaldi D; Ruoppolo G; Tilset M; Botrugno OA; Dessanti P; Minucci S; Mattevi A; Varasi M; Mai A
    Eur J Med Chem; 2015 Apr; 94():163-74. PubMed ID: 25768700
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of monoamine oxidase inhibitors and amphetamine on hypothermia produced by halothane.
    Feldberg W; Lang WJ
    Br J Pharmacol; 1970 Jan; 38(1):181-91. PubMed ID: 4391731
    [TBL] [Abstract][Full Text] [Related]  

  • 37. cis-Cyclopropylamines as mechanism-based inhibitors of monoamine oxidases.
    Malcomson T; Yelekci K; Borrello MT; Ganesan A; Semina E; De Kimpe N; Mangelinckx S; Ramsay RR
    FEBS J; 2015 Aug; 282(16):3190-8. PubMed ID: 25755053
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic tranylcypromine treatment induces functional alpha 2-adrenoceptor down-regulation in rats.
    Greenshaw AJ; Nazarali AJ; Rao TS; Baker GB; Coutts RT
    Eur J Pharmacol; 1988 Sep; 154(1):67-72. PubMed ID: 2846327
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of rat brain monoamine oxidase activity by cerebral anti-ischemic agent, ifenprodil.
    Arai Y; Nakazato K; Kinemuchi H; Tadano T; Satoh N; Oyama K; Kisara K
    Neuropharmacology; 1991 Jul; 30(7):809-12. PubMed ID: 1922690
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anorexic properties of three monoamine oxidase inhibitors.
    Willis GL; Smith GC
    Pharmacol Biochem Behav; 1982 Dec; 17(6):1135-9. PubMed ID: 7163347
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.